{
    "Trade/Device Name(s)": [
        "INFINITI System Assay for Factor II & Factor V"
    ],
    "Submitter Information": "AutoGenomics, Inc.",
    "510(k) Number": "K060564",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NPR",
        "NPQ",
        "NSU"
    ],
    "Summary Letter Date": "March 2, 2006",
    "Summary Letter Received Date": "March 3, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7280"
    ],
    "Regulation Name(s)": [
        "Factor V Leiden DNA Mutation Detection System"
    ],
    "Analyte Class(es)": [
        "hematology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Factor II (Prothrombin) G20210A",
        "Factor V Leiden G1691A"
    ],
    "Specimen Type(s)": [
        "Whole peripheral blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "INFINITI Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Polymerase Chain Reaction (PCR)",
        "Microarray",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Genotyping",
        "Mutation detection",
        "DNA hybridization"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "Reagent",
        "Software",
        "Microarray",
        "Module"
    ],
    "Document Summary": "FDA 510(k) summary for INFINITI System Assay and Analyzer for qualitative detection and genotyping of Factor II and Factor V DNA mutations in human blood using PCR and microarray technology",
    "Indications for Use Summary": "Qualitative genotyping assay for Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations in human blood, as an aid to diagnosis in evaluating patients with suspected thrombophilia",
    "fda_folder": "Hematology"
}